Provider Resources WA

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

| April 27, 2022
Ariel shot of someone taking notes or completing paperwork

Requested Actions On April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use recommended antivirals … 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

04/08/22 Health Advisory: COVID-19 Information for Providers

| April 8, 2022
Female doctor with file in front of them with two other doctors at a microscope in the background.

Requested actions Be aware, on March 29, 2022, Food and Drug Administration (FDA) amended its emergency use authorization (EUA) for Moderna COVID-19 booster dose vaccine. A new multi-dose vial is now available. It has a dark blue cap and a label with a purple border. Doses from this vial are 0.5 mL. Multi-dose vials are … 04/08/22 Health Advisory: COVID-19 Information for Providers

03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups

| March 30, 2022
Syringe in vial

Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least … 03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups

03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

| March 7, 2022
Gloved hands holding a pipette in one and a test tube in another with beakers and microscope around.

Requested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email … 03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

| March 7, 2022
person wearing white coat and stethoscope writing on a clipboard

Requested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email … 03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

03/01/2022 Provider Alert: UPDATE – COVID-19 Therapies

| February 26, 2022
stethoscope sitting on laptop keyboard

Requested Actions Be aware, providers should contact and re-dose patients who previously received the 150mg Evushield dose (see below) Be Aware, supply of COVID-19 therapeutics is not currently limited in Whatcom County. While COVID-19 case rates are decreasing in Whatcom County, some patients may benefit from therapeutics. Decision to prescribe should be based on clinical … 03/01/2022 Provider Alert: UPDATE – COVID-19 Therapies

02/25/22 Health Advisory: COVID-19 Updates for Providers

| February 25, 2022
Four doctors talking as seen from above. Two with white coats and 2 in scrubs.

Requested actions Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a … 02/25/22 Health Advisory: COVID-19 Updates for Providers

02/16/22 Health Advisory: CDC Updated COVID-19 Vaccination Guidelines, and More.

| February 15, 2022
Two hands wearing surgical gloves holding syringe and drawing from a vial

Requested Actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster dose 3 months (instead … 02/16/22 Health Advisory: CDC Updated COVID-19 Vaccination Guidelines, and More.

02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review

| February 14, 2022
person wearing white coat and stethoscope writing on a clipboard

COVID-19 Updates for Providers Requested actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster … 02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review

02/02/22 Health Advisory: FDA Provides Full Approval For Spikevax

| February 2, 2022
syringe in a vial

Requested Actions Be aware, U.S. Food and Drug Administration (FDA) granted full authorization to Moderna COVID-19 vaccine for people 18 years or older. Evidence shows the vaccine is safe and effective and manufactured with high quality. The vaccine will now be called Spikevax but has the same formulation as emergency use authorization (EUA) Moderna COVID-19 … 02/02/22 Health Advisory: FDA Provides Full Approval For Spikevax